Incorporating scientific, ethical and economic considerations into the design of clinical trials in the pharmaceutical industry: a sequential approach (Q5185882)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Incorporating scientific, ethical and economic considerations into the design of clinical trials in the pharmaceutical industry: a sequential approach |
scientific article; zbMATH DE number 3892437
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Incorporating scientific, ethical and economic considerations into the design of clinical trials in the pharmaceutical industry: a sequential approach |
scientific article; zbMATH DE number 3892437 |
Statements
Incorporating scientific, ethical and economic considerations into the design of clinical trials in the pharmaceutical industry: a sequential approach (English)
0 references
1984
0 references
data monitoring
0 references
drug administration
0 references
design of clinical trials
0 references
confidence sequence
0 references
stopping criteria
0 references
0.8193635
0 references
0.8117516
0 references
0.8009109
0 references
0 references
